Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Anna B. Halpern, Megan Othus, Nicholas P. Howard, Paul C. Hendrie, Mary-Elizabeth M. Percival, Garrett A. Hartley, Verna L. Welch, Elihu H. Estey & Roland B. Walter. (2022) Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy. Leukemia & Lymphoma 63:1, pages 142-151.
Read now
Read now
Articles from other publishers (10)
Changcheng Shi, Jian Ye, Yaping Xie, Rong Dong, Weizhong Jin, Linling Wang, Yingying Fang, Qiyuan Shan & Nengming Lin. (2022) Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China. Frontiers in Public Health 10.
Crossref
Crossref
Christina D. Bowen, Gregory B. Tallman, Morgan Hakki & James S. Lewis Ⅱ. (2019) Isavuconazole to prevent invasive fungal infection in immunocompromised adults: Initial experience at an academic medical centre. Mycoses 62:8, pages 665-672.
Crossref
Crossref
Kelly M. Pennington, Kathleen J. Yost, Patricio Escalante, Raymund R. Razonable & Cassie C. Kennedy. (2019) Antifungal prophylaxis in lung transplant: A survey of United States' transplant centers. Clinical Transplantation 33:7.
Crossref
Crossref
A.L. Bienvenu, M. Aussedat, F. Maldonado, R. Kavafian, C. Barbieri, M. Tod, C. Paillet, L. Juillard, C. Chidiac & G. Leboucher. (2019) Thesaurus for off-label indications for systemic antifungal agents. Médecine et Maladies Infectieuses 49:4, pages 275-280.
Crossref
Crossref
Jade M. Kozuch, Ashley Feist, Gordon Yung, Linda Awdishu, Steven Hays, Jonathan P. Singer & Rebecca Florez. (2018) Low dose posaconazole delayed release tablets for fungal prophylaxis in lung transplant recipients. Clinical Transplantation 32:8, pages e13300.
Crossref
Crossref
Yan Li, Mingjuan Liu, Bing Zhai, Xiaoli Zhao, Lijun Wang, Honghua Li, Shuhong Wang, Haiyan Zhu, Quanshun Wang, Chunji Gao, Wenrong Huang & Li Yu. (2018) Primary antifungal prophylaxis: decrease of invasive fungal disease incidence and reduction of risk factors in haematological patients in a 5-year retrospective study. Internal Medicine Journal 48:6, pages 713-720.
Crossref
Crossref
Hyeon Jeong Suh, Inho Kim, Joo-Youn ChoSang-In ParkSeo Hyun YoonJoo-Hee Hwang, Ji Yun Bae, Jeong-Ok Lee, Youngil Koh, Kyoung-Ho Song, Pyoeng Gyun Choe, Kyung-Sang YuEu Suk Kim, Hong Bin Kim, Soo-Mee Bang, Nam Joong Kim, Sang Hoon SongWan Beom Park & Myoung-don Oh. (2018) Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients With Hematologic Malignancies. Therapeutic Drug Monitoring 40:1, pages 115-119.
Crossref
Crossref
Rafael Cámara, Irmina Gozalbo, Manuel Jurado, Jaime Sanz, Belén Aragón & Santiago Grau. (2017) Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain. Advances in Therapy 34:9, pages 2104-2119.
Crossref
Crossref
Lei Gao, Yuqian Sun, Fanyi Meng, Mingzhe Han, He Huang, Depei Wu, Li Yu, Hanyun Ren, Xiaojun Huang & Xi Zhang. (2016) Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
Anna B. HalpernGary H. LymanThomas J. WalshDimitrios P. Kontoyiannis & Roland B. Walter. (2015) Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia. Blood 126:26, pages 2790-2797.
Crossref
Crossref